The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death
Recalled Product:
- Name: Jaundice Meter JM-103 and Jaundice Meter JM-105
- Product code: MQM
- Model numbers: JM-103: MU20606; JM-105: MU20105
- Manufacturing Dates: JM-103 June 2008 to August 2017, JM-105 September 2013 to April 2018
- Distribution Dates: JM-103 July 2008 to September 2017, JM-105 October 2013 to April 2018
- Devices Recalled in the U.S.: JM-103: 2449; JM-105: 2063
![Jaundice Jaundice](/uploads/1/2/9/2/129279140/109748382.jpg)
Device Use
The JM-103 and JM-105 Jaundice Meters are non-invasive transcutaneous bilirubinometers, which measure yellowness of subcutaneous tissue in newborn infants. The unit provides a visual digital measurement that has been shown to correlate with blood levels of bilirubin in newborn infants. High levels of bilirubin (hyperbilirubinemia) may indicate jaundice or other conditions which require medical attention.
FileHippo is the best pc software download website that offers open source, freeware. free. software download sites. CNET Download provides free downloads for Windows, Mac, iOS and Android devices across all categories of software and apps, including security, utilities, games, video and browsers. Looking to download safe free versions of the latest software, freeware, shareware and demo programs from a reputable download site? Visit FileHippo today.
Page 2 - 2 Jaundice Meter Instructions for Use (MU01380) Phototherapy WARNING: Do not use the Jaundice Meter after initiation of phototherapy or after an exchange transfusion. Results may be inaccurate under these conditions. Explanation of the Test Measuring Principle The Jaundice Meter determines the yellowness of an infant’s. Jm 103 Service Manual Dr ger Jaundice Meter JM-103 The Dr ger Jaundice Meter JM-103 is a hand-held transcutaneous bilirubin meter that provides Other Files to Download: PDF Embraer 145 Study Guide.pdf PDF Manual Engine Volvo Td 121.pdf PDF Intellisense Is310 Pir Manual.pdf.
The device is intended for use in hospitals or doctors' offices under a physician's supervision or at their direction to assist clinicians in monitoring newborn infants. The device is not intended as a standalone screening device for diagnosis of hyperbilirubinemia. It is used as a screening device along with other clinical assessments and laboratory measurements.
The JM-105 is a modification of the JM-103 jaundice meter. The basic functionality, including the measuring probe, hardware, and software used to process the measurements, are identical to the JM-103. The display of the JM-105 includes a larger screen and touchscreen, and data storage and transmission functionality.
Reason for Recall
Draeger Medical Systems, Inc. is recalling their Jaundice Meter JM-103 and JM-105 models which are used to measure bilirubin in newborn infants. The meters are being recalled because users have misinterpreted display messages that have resulted in serious injuries. Specifically, the JM-103 Meter displays three blinking dashes (- - -) and the JM-105 Meter displays dash-zero-dash (-0-) when the bilirubin level in the patient is higher than the maximum level of detection (>340µmol or 20mg/dl). Measurement of high bilirubin indicates a need for immediate medical evaluation. Some users have interpreted the two display messages as indicating a 'low' or 'zero' value instead of high bilirubin levels. When this happens, treatment may be delayed or not offered, which could lead to brain damage and possibly death in some newborns/infants.
The out of range display is visible; however, the interpretation of the reading is not intuitive or clear. Uncertainty about the out of range indication on the Jaundice meter could cause a delay of treatment in a patient with hyperbilirubinemia.
Mac os x 10.11 el capitan download. Oct 24, 2019.
The misuse of display information could increase risk for serious adverse health consequences such as acute and/or chronic brain damage or death.
Who May be Affected
Whats the best mac to buy. Newborn infants who are being monitored by a physician for hyperbilirubinemia.
What to Do
Draeger Medical issued an Urgent Medical Device Safety Notice to customers with the following instructions:
- Ensure that all JM-105 and JM-103 devices are labeled per the instructions provided by the firm in a timely manner. Draeger provided their users with labels which should be applied directly onto the meter to remind the user of the meaning of the blinking (---) for the JM-103 model, and (-0- ) for the JM-105 model. The label has a picture of the out of range display messages as they appear on the meter with three blinking (---) for JM-103 or (-0-) for JM-105: and the interpretation of the messages stating 'Measurement out of range >340µmol/L/20mg/dL.'
- Provide training to all users in the clinical environment on how to use the equipment, and ensure that they understand that this is a screening device not to be used as a standalone diagnostic device.
- Perform a blood test if they obtain a bilirubin measurement that is above the device maximum value of 20mg/dL or 340µmol.
- Complete and return the Customer Reply card sent by the firm.
- Look for a separate communication letter from Draeger which notifies those using JM-105 about the availability of upgraded software and provides instructions for sending the device to the firm if they choose to have the upgrade implemented.
Contact Information
Draeger Medical Systems, Inc.
3135 Quarry Road, Telford Pennsylvania
USA 18969-1042
3135 Quarry Road, Telford Pennsylvania
USA 18969-1042
Full List of Affected Devices
Date Recall Initiated
Jm 103 Jaundice Meter Manual Online
May 21, 2018
Additional Resources
How do I report a problem?
Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program either online, by regular mail or by FAX to 1-800-FDA-0178.
Regulated Product(s)
Topic(s)
-
|
Drager Jm 103 Jaundice Meter
| |||||||||||||||||||||||||||
Device Design | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The firm, Drager, sent an 'Urgent Medical Device Safety Notices' were distributed to customers on 5/15/18. The letter described the product, problem and actions to be taken. The letters instruct customers to perform the following: Enclosed with this letter are label/s and instructions on how and hwere to apply the label onto your device/s. Please make sure that all JM-105/JM-103 devices in your hospital are labeled according to the instructions in a timely manner. Please make sure that in your clinical environment the users are trained in the use of the equipment and the clinical workflow is set up in a way that the device is not used as a diagnostic device. In case of any uncertainty (e.g. risk factors cannot be evaluated), a blood test needs to be performed. The risk factors according to the Guideline of American Academy of Pediatrics are summarized in the attached Sample Usage Protocol Template as well as the recommended method to use the device as intended in a clinical environment. Please completed and return the attached Customer Reply card. If you have any questions regarding, please call 1-800-437-2437(press 1 at the prompt than 32349) between the hours of 8:00am-4:30pm EST. | |||||||||||||||||||||||||||
6711 | |||||||||||||||||||||||||||
Worldwide Distribution: US (nationwide) including states of: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY; and countries of: Algeria, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belgium, Benin, Bolivia, Bosnia-Herz., Botswana, Brazil, British Virgin Islands, Brunei Darussalam, Bulgaria, Burkina-Faso, Cambodia, Canada, Chile, Columbia, Congo, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, El Salvador, Estonia, Finland, France, French Guiana, Macedonia, Georgia, Germany, Ghana, Greece, Greenland, Guadeloupe, Guam, Guatemala, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jordan, Kazakhstan, Kosovo, Kuwait, Laos, Latvia, Lebanon, Libya, Lithuania, Malaysia, Mayotte, Mexico, Mongolia, Morocco, Mozambique, Myanmar, Namibia, Nicaragua, Nigeria, Norway, Nepal, Netherlands, New Caledonia, New Zealand, Nigeria, Norway, Oman, Pakistan, Panama, Peru, Philippines, Poland, Portugal, Qatar, Reunion, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sri Lanka, St Vincent, St Pier Miquel, Sweden, Switzerland, Tadzhikistan, Tanzania, Thailand, Trinidad Tobago, Tunisia, Turkey, Turkmenistan, United Kingdom, Uruguay, UAE, Venezuela, Vietnam, and Zimbabwe. | |||||||||||||||||||||||||||
TPLC Device Report | |||||||||||||||||||||||||||
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes. | |||||||||||||||||||||||||||
510(K) Database | 510(K)s with Product Code = MQM and Original Applicant = DRAEGER MEDICAL SYSTEMS, INC. |